CAS: 2162962-69-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-(4-Hydroxy-3-methylphenyl)quinolin-7-ol REF: IN-DA01EOJWCAS: 2162962-69-6 | 97% | 45.00 €~465.00 € | Tue 10 Dec 24 |
 | CU-CPT9b REF: TM-T7302CAS: 2162962-69-6 | 98.10% | 43.00 €~559.00 € | Mon 16 Dec 24 |
 | CU-CPT9b REF: 3D-MLD96269CAS: 2162962-69-6 | Min. 95% | To inquire | Tue 21 Jan 25 |
4-(4-Hydroxy-3-methylphenyl)quinolin-7-ol
CAS:2162962-69-6
Formula:
C16H13NO2
Purity:
97%
Color and Shape:
Solid
Molecular weight:
251.2799
Ref: IN-DA01EOJW
| 1mg | 45.00 € | ||
| 5mg | 57.00 € | ||
| 10mg | 84.00 € | ||
| 25mg | 114.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
CU-CPT9b
CAS:2162962-69-6
CU-CPT9b (TLR8-specific antagonist 1) is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 …
Formula:
C16H13NO2
Purity:
98.10%
Color and Shape:
Solid
Molecular weight:
251.28
Ref: TM-T7302
| 1mg | 52.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 159.00 € | ||
| 25mg | 256.00 € | ||
| 50mg | 373.00 € | ||
| 100mg | 559.00 € | ||
| 1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
CU-CPT9b
CAS:2162962-69-6
CU-CPT9b is a potent compound that has been shown to have clinical relevance in the …
Formula:
C16H13NO2
Purity:
Min. 95%
Molecular weight:
251.28 g/mol
Ref: 3D-MLD96269
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
